{"gene":"UCP2","run_date":"2026-06-10T10:51:56","timeline":{"discoveries":[{"year":2014,"finding":"UCP2 functions as a metabolite transporter that exchanges malate, oxaloacetate, and aspartate for phosphate plus a proton across the mitochondrial membrane, thereby exporting C4 compounds out of mitochondria. This limits oxidation of acetyl-CoA-producing substrates (e.g., glucose) and enhances glutaminolysis. Reconstitution of UCP2 in lipid vesicles directly demonstrated this transport activity.","method":"Reconstitution in lipid vesicles (transport assay), siRNA silencing in HepG2 cells with metabolite profiling, membrane potential and ATP:ADP ratio measurements","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct reconstitution in lipid vesicles with transport assay, combined with cellular loss-of-function and metabolite profiling; multiple orthogonal methods in single rigorous study","pmids":["24395786"],"is_preprint":false},{"year":2020,"finding":"In KRAS-mutant pancreatic ductal adenocarcinoma cells, UCP2 catalyses mitochondrial aspartate efflux required for cytosolic NADPH production via the rewired glutamine metabolic pathway. UCP2 silencing decreased glutaminolysis, lowered NADPH/NADP+ and glutathione/GSSG ratios, raised ROS, and strongly suppressed KRASmut PDAC growth in vitro and in vivo.","method":"siRNA/shRNA silencing of UCP2 in PDAC cell lines, metabolic flux analysis, ROS measurements, xenograft mouse models","journal":"Nature metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (knockdown, metabolomics, redox assays, in vivo xenograft), replicates and extends the C4 transport mechanism from PMID 24395786","pmids":["33230296"],"is_preprint":false},{"year":2011,"finding":"UCP2 prevents mitochondrial glucose oxidation and facilitates glycolysis via a substrate-shunting mechanism in human pluripotent stem cells. Ectopic UCP2 expression perturbs the metabolic transition during differentiation and impairs hPSC differentiation. UCP2 repression is required for full differentiation potential.","method":"Ectopic UCP2 overexpression in hPSCs, siRNA knockdown, metabolic flux measurements (O2 consumption, glycolysis), differentiation assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain- and loss-of-function experiments with specific metabolic and functional phenotypic readouts, multiple orthogonal methods in single study","pmids":["22085932"],"is_preprint":false},{"year":2015,"finding":"UCP2 regulates NLRP3 inflammasome activation through stimulation of fatty acid (lipid) synthesis via fatty acid synthase (FASN) upregulation in macrophages. UCP2-deficient macrophages showed impaired lipid synthesis, downregulated FASN, and suppressed NLRP3-mediated caspase-1 activation and IL-1β/IL-18 production. FASN inhibition phenocopied UCP2 deficiency.","method":"UCP2-deficient mice, shRNA knockdown of FASN, chemical inhibitors (C75, cerulenin), LPS challenge, caspase-1 activity assay, cytokine measurement","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO mice plus shRNA/pharmacologic intervention with epistasis between UCP2 and FASN established by multiple methods","pmids":["25574840"],"is_preprint":false},{"year":2019,"finding":"Selective microglial deletion of UCP2 prevented HFD-induced changes in mitochondrial dynamics and function, microglia activation, and hypothalamic inflammation, protecting mice from diet-induced obesity with decreased feeding and increased energy expenditure.","method":"Microglial-specific Ucp2 conditional knockout mice, HFD feeding, mitochondrial dynamics imaging, synaptic input analysis, POMC neuron activation assays","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO with defined cellular and physiological phenotypes, multiple functional readouts","pmids":["31495690"],"is_preprint":false},{"year":2008,"finding":"UCP2 is expressed at significantly higher levels in pancreatic alpha-cells than beta-cells, where it causes greater mitochondrial uncoupling and lower oxidative phosphorylation efficiency. Reducing UCP2 activity in alpha-cells increased ATP synthesis and altered glucagon secretion in response to low glucose.","method":"UCP2-/- mice, mitochondrial membrane potential measurements, ATP/O ratio, glucagon secretion assays in vitro and in vivo","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — UCP2 knockout mice combined with mitochondrial function assays and secretion measurements; multiple orthogonal readouts","pmids":["18701716"],"is_preprint":false},{"year":2013,"finding":"Alpha-cell-specific UCP2 deletion impairs blood glucose recovery during hypoglycemia due to attenuated glucagon secretion. UCP2-deleted alpha-cells have higher intracellular ROS from enhanced mitochondrial coupling, which disrupts stimulus-secretion coupling. UCP2 inhibitor genipin on murine and human islets phenocopied the genetic deletion.","method":"Alpha-cell-specific UCP2 knockout mice, hypoglycemia challenge, ROS measurement, glucagon secretion assay, genipin pharmacology on murine and human islets","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific KO with mechanistic ROS and secretion readouts; validated with pharmacologic inhibition in human islets","pmids":["23434936"],"is_preprint":false},{"year":2022,"finding":"KLF2 (Krüppel-like factor 2) mediates fluid shear stress-dependent regulation of UCP2 expression in endothelial cells by directly binding the UCP2 promoter. EC-specific Ucp2 deletion promotes atherogenesis; UCP2 suppresses FoxO1-driven proinflammatory transcription via AMPK phosphorylation.","method":"Shear stress simulation, KLF2 ChIP on UCP2 promoter, EC-specific Ucp2 KO mice, adeno-associated virus-mediated UCP2 overexpression, RNA-seq, carotid atherosclerosis model","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP binding assay, cell-type-specific KO, AAV overexpression, RNA-seq; multiple orthogonal methods establishing promoter regulation and downstream signaling","pmids":["35899624"],"is_preprint":false},{"year":2004,"finding":"The RNA-binding protein hnRNPK binds ucp2 mRNA through sites in the 3'-untranslated region and associates with polysome-coated mitochondria. Exogenous hnRNPK augments insulin-induced mitochondrial UCP2 protein levels without a corresponding increase in ucp2 mRNA, indicating translational regulation.","method":"Yeast three-hybrid screen, polysome fractionation, mitochondrial isolation and Western blot, hnRNPK overexpression","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast three-hybrid plus polysome fractionation plus protein quantitation; single lab but three orthogonal approaches","pmids":["15485813"],"is_preprint":false},{"year":2001,"finding":"In vivo muscle gene transfer of UCP2 cDNA increased UCP2 protein 3.6-fold and caused a significant reduction in mitochondrial membrane potential, demonstrating that UCP2 can uncouple respiration when expressed in skeletal muscle mitochondria.","method":"Intramuscular plasmid injection in rats, Western blot for UCP2 protein, spectrofluorometry and flow cytometry for mitochondrial membrane potential","journal":"International journal of obesity and related metabolic disorders","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vivo gene transfer with protein-level confirmation and functional mitochondrial readout; single lab, two orthogonal methods","pmids":["11244460"],"is_preprint":false},{"year":2005,"finding":"LPS injection in rats recruits UCP2 protein to liver mitochondria (3-fold increase in 3H-GTP binding sites), causes lower mitochondrial membrane potential in hepatocytes, and increases H2O2 production inhibitable by GDP, indicating that recruited UCP2 causes mild uncoupling sufficient to reduce mitochondrial ROS production.","method":"In vivo LPS injection, 3H-GTP binding assay, real-time RT-PCR, Western blot, JC1 fluorescence for membrane potential, H2O2 production assay","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (GTP binding, membrane potential, ROS) in single lab establishing protein-level UCP2 recruitment and functional consequence","pmids":["15694840"],"is_preprint":false},{"year":2000,"finding":"Transfected human UCP2 localizes exclusively to mitochondria in CHO cells, establishing its subcellular compartment by direct imaging.","method":"Transfection of human UCP2 into CHO cells, confocal immunofluorescence microscopy","journal":"International journal of obesity and related metabolic disorders","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct localization by immunofluorescence in transfected cells; single method, single lab","pmids":["10849580"],"is_preprint":false},{"year":2002,"finding":"PPARα activation in INS-1 insulinoma cells doubles UCP2 expression and reduces glucose-stimulated insulin secretion; this suppression is prevented by CPT-I inhibitor etomoxir, linking PPARα-stimulated fatty acid oxidation through UCP2 to impaired beta-cell insulin secretion.","method":"Adenovirus-mediated PPARα overexpression, clofibric acid treatment, CPT-I inhibitor etomoxir, insulin secretion assay, UCP2 mRNA measurement","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — adenoviral overexpression plus pharmacologic epistasis (etomoxir rescue) linking PPARα→UCP2→insulin secretion; single lab, multiple approaches","pmids":["12032169"],"is_preprint":false},{"year":2014,"finding":"UCP2 overexpression in cancer cells restores balance toward oxidative phosphorylation, increases AMPK signaling, downregulates HIF-1α expression, and represses malignant phenotypes. UCP2 acted by controlling substrate routing to mitochondria rather than via membrane potential uncoupling.","method":"UCP2 overexpression in cancer cell lines, AMPK signaling analysis, HIF-1α expression, metabolic enzyme expression, tumor phenotype assays","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function with multiple signaling and metabolic readouts; single lab, mechanistic pathway placement","pmids":["24853548"],"is_preprint":false},{"year":2017,"finding":"UCP2 overexpression activates PFKFB2 via an AKT-dependent signaling pathway in skin cells, elevating fructose-2,6-bisphosphate, PFK-1 activity, glucose uptake and lactate production, promoting glycolysis and cell transformation. PFKFB2 inhibition reversed UCP2-mediated transformation.","method":"UCP2 overexpression in JB6 skin cells, PFKFB2 knockdown/inhibition, 13C glucose tracing, AKT inhibition, cell transformation assay","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis between UCP2 and PFKFB2/AKT established by genetic and pharmacologic interventions; single lab, multiple orthogonal approaches","pmids":["29221144"],"is_preprint":false},{"year":2017,"finding":"UCP2 controls embryonic neurogenesis by inhibiting ROS production; when UCP2 is knocked down or conditionally deleted in developing neocortex, ROS increases, Yap protein accumulates (via decreased ubiquitin-proteasome degradation), progenitor proliferation increases and differentiation decreases. Yap downregulation rescues the UCP2-deficiency phenotype.","method":"UCP2 knockdown and conditional KO in mouse embryonic brain, ROS measurement, Yap protein quantitation, Yap genetic rescue experiment","journal":"Stem cells (Dayton, Ohio)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with genetic rescue establishing UCP2→ROS→Yap pathway; single lab, multiple methods","pmids":["28276603"],"is_preprint":false},{"year":2017,"finding":"UCP2 controls pancreas development by regulating ROS levels: Ucp2-/- fetuses show increased pancreas size, more α- and β-cells, and expanded PDX1+ progenitors associated with increased nuclear NRF2 translocation (indicating increased ROS) and AKT phosphorylation. N-acetylcysteine administration to pregnant Ucp2-/- mice alleviated the phenotype.","method":"Ucp2 knockout mice, fetal pancreas analysis, NRF2 nuclear translocation assay, AKT phosphorylation, NAC antioxidant rescue","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO phenotype plus pharmacologic rescue with antioxidant establishing ROS-AKT mechanism; single lab, multiple approaches","pmids":["29079704"],"is_preprint":false},{"year":2019,"finding":"UCP2 deficiency in colon tumors increases oxidized glutathione and protein oxidation, alters glycolytic pathways, and promotes phospholipid synthesis, limiting NADPH availability for antioxidant defense. UCP2 loss enhances colon and intestinal tumorigenesis in AOM/DSS and ApcMin/+ mouse models.","method":"Ucp2 KO in AOM/DSS and ApcMin/+ mouse cancer models, NADPH/NADP+ measurement, glutathione oxidation, phospholipid synthesis assays, tumor quantification","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two independent in vivo cancer models plus mechanistic metabolic readouts; single lab","pmids":["31461648"],"is_preprint":false},{"year":2022,"finding":"UCP2 acts as a metabolic oxygen sensor in cardiomyocytes: under moderate hypoxia, UCP2 expression increases, promotes a glycolytic shift, increases acetyl-CoA levels and histone acetylation, and promotes cardiomyocyte cell cycle activity. UCP2-KO mice under hypoxia show reduced cell cycle activity, increased fibrosis and DNA damage.","method":"UCP2-KO mouse model, neonatal rat ventricular myocyte culture under hypoxia, acetyl-CoA measurement, histone acetylation assay, cell cycle analysis, mitochondrial membrane potential, mtDNA quantification","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mice plus in vitro mechanistic assays linking UCP2 to acetyl-CoA and histone acetylation; single lab, multiple orthogonal methods","pmids":["35771638"],"is_preprint":false},{"year":2015,"finding":"Inhibition or deletion of FABP4/aP2 in macrophages elevates intracellular free fatty acids and upregulates UCP2, reducing ER stress and ROS. Silencing UCP2 in FABP4-deficient macrophages negates the protective effect and increases ER stress, placing UCP2 downstream of FABP4/FFA equilibrium in regulating macrophage oxidative stress.","method":"FABP4 KO macrophages, FABP4 pharmacologic inhibition (HTS01037), UCP2 siRNA rescue, mitochondrial protein carbonylation, ROS measurement, ER stress marker expression","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis established by genetic KO and siRNA rescue with multiple oxidative stress readouts; single lab","pmids":["25582199"],"is_preprint":false},{"year":2017,"finding":"FABP4 regulates macrophage redox signaling and NLRP3 inflammasome activation via control of UCP2 expression: FABP4-/- macrophages show reduced mitochondrial protein oxidation, attenuated mtUPR, reduced NLRP3/caspase-1 and IL-1β secretion; these effects are partially rescued by UCP2 silencing in FABP4-null macrophages.","method":"FABP4-/- macrophages, UCP2 silencing rescue, mitochondrial protein cysteine oxidation, mtUPR markers (HSP60, ClpP, LonP1), caspase-1 cleavage, IL-1β secretion","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis established by KO plus siRNA rescue with multiple mechanistic readouts; replication by same lab of FABP4-UCP2 axis","pmids":["27795298"],"is_preprint":false},{"year":2008,"finding":"Upregulation of UCP2 in NASH liver mitochondria induces increased proton leak, which correlates with increased mitochondrial H2O2 production and decreased hepatic ATP content independent of ATPase dysfunction.","method":"Mitochondrial isolation from NASH human and rat liver, proton leak kinetics, H2O2 production assay, HNE-protein adduct measurement, UCP2 protein expression (Western blot), ATP measurement","journal":"Gut","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct mitochondrial functional measurements in human and rat tissue correlating UCP2 protein level with proton leak and ROS; two species, multiple readouts","pmids":["18308829"],"is_preprint":false},{"year":2012,"finding":"UCP2 inhibition (by genipin or siRNA) in pancreatic adenocarcinoma cells increases ROS production, triggers ROS-dependent nuclear translocation of GAPDH, formation of autophagosomes, and LC3-II expression. UCP2 overexpression reduces basal autophagy. Autophagy induced by UCP2 inhibition mediates ROS-dependent cell death.","method":"Genipin treatment, UCP2 siRNA knockdown, UCP2 overexpression, GAPDH localization assay, autophagosome formation, LC3-II Western blot, autophagy inhibitors (chloroquine, 3-MA), NAC ROS scavenging","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple complementary interventions (pharmacologic + siRNA + OE) with epistasis via inhibitors; single lab","pmids":["23124112"],"is_preprint":false},{"year":2021,"finding":"UCP2 mediates the interaction between high-salt-induced ROS and autophagy/mitophagy to preserve cell viability in endothelial and renal tubular cells; UCP2 silencing reduces autophagy and mitophagy flux, while UCP2 overexpression increases them. Excessive ROS accumulation upon UCP2 silencing turns off autophagy.","method":"UCP2 siRNA silencing, UCP2 overexpression, autophagy flux assay, mitophagy markers, ROS measurement, Tat-Beclin 1 autophagy inducer rescue in UCP2-silenced cells","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with pharmacologic rescue establishing UCP2→ROS→autophagy axis; single lab, multiple orthogonal methods","pmids":["34625529"],"is_preprint":false},{"year":2024,"finding":"UCP2 overexpression in retinal endothelial cells protects against hyperglycemia-induced oxidative stress and senescence by maintaining NAD+ levels and thereby promoting SIRT3 expression and activity; selective SIRT3 inhibition (3-TYP) abolishes the UCP2-mediated protective effect.","method":"Adenovirus-mediated UCP2 overexpression and knockdown in HRECs, NAD+ measurement, SIRT3 activity assay, 3-TYP inhibitor epistasis, ROS flow cytometry, SA-β-gal senescence assay","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain/loss-of-function with pharmacologic epistasis establishing UCP2→NAD+→SIRT3 pathway; single lab, multiple methods","pmids":["38175638"],"is_preprint":false},{"year":2025,"finding":"In pancreatic β cells under T2DM conditions, IL-1β drives autoinflammation through the UCP2/mtDNA/STING axis: UCP2 inhibition reduces mtDNA release and STING activation, thereby eliminating β-cell autoinflammation.","method":"UCP2 inhibitor genipin, nanomedicine (Mito-G) targeting β-cell mitochondria, STING pathway analysis, mtDNA quantitation, IL-1β stimulation model, in vivo T2DM mouse model","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — targeted pharmacologic UCP2 inhibition with pathway-specific readouts (mtDNA, STING); single study but in vitro + in vivo, mechanistic pathway established","pmids":["40707441"],"is_preprint":false},{"year":2021,"finding":"UCP2 controls autophagy in cardiomyocytes during sepsis via AMPK: UCP2 silencing reduces AMPK phosphorylation (correlated with changes in upstream kinases pLKB1 and CAMKK2), limits autophagy protein upregulation, and aggravates mitochondrial injury; AMPK agonist AICAR rescues UCP2-KO cardiac phenotype.","method":"UCP2 KO mice (CLP sepsis model), UCP2 siRNA in H9C2 cells, AICAR treatment, AMPK phosphorylation, LKB1/CAMKK2 expression, autophagy protein assay (Beclin-1, LC3-I/II, pULK1)","journal":"Annals of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO animal plus in vitro silencing with AICAR epistasis establishing UCP2→AMPK→autophagy pathway; single lab","pmids":["33708886"],"is_preprint":false},{"year":2022,"finding":"UCP2 silencing in T-ALL cell lines decreases malate export from mitochondria, disrupting TCA cycle flux and impairing cell proliferation. T-ALL cells relying on glutamine-dependent oxidative metabolism redirect to glycolysis upon UCP2 silencing.","method":"UCP2 siRNA in T-ALL cell lines, 13C metabolic tracing, mitochondrial respiration measurement, glycolysis assay, lipid synthesis measurement","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isotopic tracing plus respiratory measurements establishing UCP2 as TCA cycle metabolite exporter in leukemia; single lab, multiple methods","pmids":["36275699"],"is_preprint":false},{"year":1998,"finding":"The mouse UCP2 gene spans ~6.3 kb with 8 exons and 7 introns. The promoter lacks TATA and CAAT boxes and is GC-rich; a region from -160 to -678 bp exhibits strong positive regulatory activity. A single transcription start site 369 bp upstream of the translational start was identified.","method":"Genomic cloning, primer extension analysis, promoter-reporter transfection assays in 6 cell lines","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter deletion analysis by reporter assay in multiple cell lines combined with primer extension; single lab","pmids":["9710252"],"is_preprint":false},{"year":2004,"finding":"UCP2 overexpression in 3T3-L1 adipocytes reduces mitochondrial membrane potential and ATP production, increases caspase expression, decreases Bcl-2/Bax ratio, and induces apoptosis. Physiological doses of 1,25-(OH)2-D3 restore mitochondrial membrane potential and protect against UCP2-induced apoptosis via suppression of mitochondrial Ca2+.","method":"UCP2 overexpression in 3T3-L1 cells, mitochondrial membrane potential measurement, ATP assay, caspase and Bcl-2/Bax expression, Ca2+ measurement, 1,25-(OH)2-D3 dose-response","journal":"FASEB journal","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, overexpression model with standard apoptosis readouts; limited mechanistic depth on UCP2 mechanism itself","pmids":["15231722"],"is_preprint":false},{"year":2001,"finding":"Insulin dose-dependently increases UCP2 mRNA expression in rat skeletal muscle in vitro, independent of glucose uptake. AICAR (AMPK activator) mimics this increase, suggesting AMPK as a mediator of contraction-induced UCP2 upregulation.","method":"Isolated rat EDL muscle in vitro incubation, insulin dose-response, electrical contraction, AICAR treatment, RT-PCR for UCP2/UCP3 mRNA","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — mRNA-level readout with pharmacologic AMPK activator; no protein-level or direct AMPK epistasis confirmation; single lab","pmids":["11322761"],"is_preprint":false},{"year":2021,"finding":"Chronic hypoxanthine treatment upregulates UCP2 in skeletal muscle, leading to decreased energy substrate storage and enhanced glycolysis causing muscular fatigue. Muscle-specific UCP2 knockout via AAV reversed hypoxanthine-induced effects.","method":"Dietary hypoxanthine supplementation in mice, intra-muscle AAV-mediated UCP2 KO, exercise performance test, glycolysis and energy storage assays","journal":"Frontiers in physiology","confidence":"Low","confidence_rationale":"Tier 3 / Moderate — muscle-specific KO via AAV establishes UCP2 requirement, but mechanism of hypoxanthine→UCP2 induction not fully characterized; single lab","pmids":["33746782"],"is_preprint":false}],"current_model":"UCP2 is a mitochondrial inner membrane transporter (member of SLC25 family) that functions primarily as a C4 metabolite (malate, oxaloacetate, aspartate) exporter rather than a canonical proton-leak uncoupler; by exporting C4 compounds it limits mitochondrial glucose oxidation, promotes glycolysis, and facilitates glutaminolysis—thereby regulating cellular redox homeostasis (NADPH/ROS balance), AMPK and HIF-1α signaling, autophagy/mitophagy, and the secretion of hormones such as insulin and glucagon from pancreatic islets, while also serving as a mechanosensitive gene in endothelial cells under transcriptional control of KLF2."},"narrative":{"mechanistic_narrative":"UCP2 is a mitochondrial inner-membrane transporter that, rather than acting solely as a proton-leak uncoupler, exports C4 metabolites—malate, oxaloacetate, and aspartate—in exchange for phosphate plus a proton, a transport activity demonstrated directly by reconstitution in lipid vesicles [PMID:24395786]. By shunting these substrates out of mitochondria, UCP2 limits oxidation of acetyl-CoA-generating fuels such as glucose, promotes glycolysis, and enhances glutaminolysis [PMID:24395786, PMID:22085932, PMID:36275699], thereby positioning the protein as a node controlling cellular redox balance and metabolic fate. This substrate-routing function supports cytosolic NADPH production and glutathione-based antioxidant defense: in KRAS-mutant pancreatic adenocarcinoma, UCP2-mediated aspartate efflux sustains NADPH/GSH and suppresses ROS to drive tumor growth [PMID:33230296], and UCP2 loss in colon tumors limits NADPH availability and enhances tumorigenesis [PMID:31461648]. Through its control of ROS, UCP2 governs diverse downstream programs—AMPK activation with HIF-1α suppression and restraint of malignant phenotypes [PMID:24853548], AKT/PFKFB2-driven glycolysis [PMID:29221144], ROS-dependent stabilization of Yap during neurogenesis [PMID:28276603], and pancreatic progenitor expansion via NRF2/AKT signaling [PMID:29079704]. UCP2 also modulates autophagy and mitophagy in an ROS-dependent manner [PMID:23124112, PMID:34625529, PMID:33708886] and shapes innate immunity by supporting FASN-dependent lipid synthesis for NLRP3 inflammasome activation in macrophages [PMID:25574840] and by driving the mtDNA/STING autoinflammatory axis in β cells [PMID:40707441]. Physiologically, UCP2 regulates hormone secretion from pancreatic islets—uncoupling and tuning ROS to control glucagon release from α cells [PMID:18701716, PMID:23434936]—and acts as a KLF2-controlled, shear-stress-responsive endothelial gene that suppresses FoxO1-driven inflammation via AMPK to protect against atherogenesis [PMID:35899624]. UCP2 localizes to mitochondria [PMID:10849580], and its abundance is set both transcriptionally and translationally, including hnRNPK-mediated control of UCP2 protein levels through its 3'-UTR [PMID:15485813].","teleology":[{"year":1998,"claim":"Before its function was understood, the genomic and transcriptional architecture of UCP2 had to be defined to enable regulatory studies.","evidence":"Genomic cloning, primer extension, and promoter-reporter assays in multiple cell lines for the mouse gene","pmids":["9710252"],"confidence":"Medium","gaps":["Does not identify the trans-acting factors binding the positive regulatory region","Promoter analysis in mouse only"]},{"year":2000,"claim":"Establishing UCP2's subcellular compartment was prerequisite to any mitochondrial mechanism, confirmed by direct imaging.","evidence":"Transfection of human UCP2 into CHO cells with confocal immunofluorescence","pmids":["10849580"],"confidence":"Medium","gaps":["Single localization method in an overexpression system","Does not address submitochondrial topology"]},{"year":2001,"claim":"An early functional question—whether UCP2 can actually uncouple respiration—was answered in vivo in skeletal muscle.","evidence":"Intramuscular plasmid gene transfer in rats with membrane potential readouts","pmids":["11244460"],"confidence":"Medium","gaps":["Overexpression may force non-physiological uncoupling","Does not distinguish proton leak from metabolite transport"]},{"year":2008,"claim":"Cell-type-resolved analysis showed UCP2 tunes islet hormone secretion, linking mitochondrial coupling to glucagon physiology.","evidence":"UCP2-/- mice with mitochondrial membrane potential, ATP/O, and glucagon secretion assays comparing alpha- and beta-cells","pmids":["18701716"],"confidence":"High","gaps":["Mechanism connecting coupling efficiency to secretory machinery not detailed","Whole-body KO does not isolate alpha-cell-autonomous effects"]},{"year":2004,"claim":"UCP2 abundance was shown to be set post-transcriptionally, revealing translational control as a regulatory layer.","evidence":"Yeast three-hybrid screen, polysome fractionation, and hnRNPK overexpression tracking UCP2 protein vs mRNA","pmids":["15485813"],"confidence":"Medium","gaps":["Single lab; mechanism of insulin-induced translational activation not fully resolved","Physiological importance in vivo untested"]},{"year":2014,"claim":"The defining mechanistic advance recast UCP2 as a C4-metabolite exporter rather than a simple uncoupler, explaining how it reroutes glucose vs glutamine metabolism.","evidence":"Reconstitution in lipid vesicles with transport assay plus siRNA silencing and metabolite profiling in HepG2 cells","pmids":["24395786"],"confidence":"High","gaps":["Relative in vivo contribution of transport vs residual proton leak not quantified","Structural basis of substrate selectivity unresolved"]},{"year":2013,"claim":"Alpha-cell-specific deletion tied UCP2-controlled ROS to stimulus-secretion coupling and counter-regulatory glucagon release during hypoglycemia.","evidence":"Alpha-cell-specific KO mice with hypoglycemia challenge, ROS and secretion assays, validated by genipin in human islets","pmids":["23434936"],"confidence":"High","gaps":["Genipin is not UCP2-selective","Link between ROS and exocytotic machinery not molecularly defined"]},{"year":2015,"claim":"UCP2 was placed in innate immune control by coupling its activity to FASN-dependent lipid synthesis needed for NLRP3 inflammasome activation.","evidence":"UCP2-deficient mice, FASN knockdown and inhibitors, caspase-1 and cytokine assays establishing UCP2-FASN epistasis","pmids":["25574840"],"confidence":"High","gaps":["How metabolite transport drives FASN upregulation mechanistically not shown","Relationship to UCP2's antioxidant role in same cells unclear"]},{"year":2014,"claim":"Independent cancer studies linked UCP2 substrate routing to AMPK/HIF-1α signaling and the glycolytic phenotype.","evidence":"UCP2 overexpression in cancer lines with AMPK, HIF-1α, and tumor phenotype readouts","pmids":["24853548"],"confidence":"Medium","gaps":["Causal order between metabolic shift and AMPK/HIF-1α not fully dissected","Single overexpression context"]},{"year":2017,"claim":"Multiple developmental and signaling studies converged on UCP2-controlled ROS as the effector regulating Yap, NRF2/AKT, and progenitor fate.","evidence":"Conditional KO/knockdown in neocortex and pancreas with ROS, Yap, NRF2 readouts and genetic/antioxidant rescue; AKT/PFKFB2 epistasis in skin cells with 13C tracing","pmids":["28276603","29079704","29221144"],"confidence":"Medium","gaps":["Whether ROS effects stem from metabolite transport or residual uncoupling not resolved per study","Tissue specificity of downstream effectors not generalized"]},{"year":2020,"claim":"UCP2-dependent aspartate efflux was shown to fuel cytosolic NADPH/glutathione and ROS control required for KRAS-mutant PDAC growth, extending the C4 transport model to cancer redox biology.","evidence":"siRNA/shRNA silencing in PDAC lines, metabolic flux, redox assays, and xenografts","pmids":["33230296"],"confidence":"High","gaps":["Generalizability beyond KRAS-mutant context not addressed","Does not test whether transport-dead UCP2 abolishes the effect"]},{"year":2019,"claim":"In vivo cancer models showed UCP2 loss impairs NADPH-dependent antioxidant defense and promotes intestinal tumorigenesis, and microglial UCP2 was tied to diet-induced obesity and hypothalamic inflammation.","evidence":"Ucp2 KO in AOM/DSS and ApcMin/+ models with NADPH/GSH readouts; microglia-specific conditional KO with HFD and mitochondrial dynamics imaging","pmids":["31461648","31495690"],"confidence":"Medium","gaps":["Tissue-of-origin cell-autonomy in tumor models not fully isolated","Connection between microglial mitochondrial dynamics and feeding circuits incompletely mapped"]},{"year":2022,"claim":"UCP2 was identified as a KLF2-controlled, shear-stress-responsive endothelial gene that restrains FoxO1 inflammation via AMPK and protects against atherosclerosis, and as a metabolic oxygen sensor regulating cardiomyocyte cell cycle through acetyl-CoA/histone acetylation.","evidence":"KLF2 ChIP on UCP2 promoter, EC-specific KO, AAV overexpression, RNA-seq, atherosclerosis model; UCP2-KO cardiomyocytes under hypoxia with acetyl-CoA and histone acetylation assays","pmids":["35899624","35771638"],"confidence":"High","gaps":["Direct biochemical link between transport activity and AMPK phosphorylation not established","How UCP2 senses oxygen mechanistically remains open"]},{"year":2022,"claim":"Isotopic tracing confirmed UCP2 exports malate to sustain TCA flux in glutamine-dependent leukemia, reinforcing the transporter model across cancer types.","evidence":"UCP2 siRNA in T-ALL lines with 13C tracing, respiration, and glycolysis assays","pmids":["36275699"],"confidence":"Medium","gaps":["Single lineage tested","Does not measure direct transport vs indirect metabolic adaptation"]},{"year":2025,"claim":"Recent work extended UCP2 into autophagy/mitophagy control and a β-cell mtDNA/STING autoinflammatory axis, integrating its redox role with cell survival and inflammation.","evidence":"Gain/loss-of-function with ROS, autophagy flux, SIRT3, mtDNA and STING readouts across endothelial, renal, cardiac, and β-cell systems, including genipin and nanomedicine targeting in T2DM models","pmids":["23124112","34625529","33708886","38175638","40707441"],"confidence":"Medium","gaps":["Genipin specificity limits causal attribution to UCP2","Whether mtDNA release is a direct consequence of transport activity unknown"]},{"year":null,"claim":"It remains unresolved how UCP2's biochemically defined C4-metabolite transport activity mechanistically generates its many downstream signaling outputs (AMPK, HIF-1α, Yap, STING) and whether residual proton-leak uncoupling contributes independently.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No transport-dead mutant used to separate transport from uncoupling in signaling phenotypes","No high-resolution structure defining substrate selectivity","Quantitative in vivo flux contribution of UCP2 transport not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,27]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[0,27]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,8,11,21]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,2,27]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[1,10,17,24]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,20,25]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[22,23,26]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,13,14]}],"complexes":[],"partners":["HNRNPK"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P55851","full_name":"Dicarboxylate carrier SLC25A8","aliases":["Mitochondrial uncoupling protein 2","UCP 2","Solute carrier family 25 member 8","UCPH"],"length_aa":309,"mass_kda":33.2,"function":"Antiporter that exports dicarboxylate intermediates of the Krebs cycle in exchange for phosphate plus a proton across the inner membrane of mitochondria, a process driven by mitochondrial motive force with an overall impact on glycolysis, glutaminolysis and glutathione-dependent redox balance. Continuous export of oxaloacetate and related four-carbon dicarboxylates from mitochondrial matrix into the cytosol negatively regulates the oxidation of acetyl-CoA substrates via the Krebs cycle, lowering the ATP/ADP ratio and reactive oxygen species (ROS) production (PubMed:24395786). May mediate inducible proton entry into the mitochondrial matrix affecting ATP turnover as a protection mechanism against oxidative stress. The proton currents are most likely associated with fatty acid flipping across the inner membrane of mitochondria in a metabolic process regulated by free fatty acids and purine nucleotides (By similarity) (PubMed:11171965, PubMed:11278935, PubMed:22524567, PubMed:26182433, PubMed:33373220). Regulates the use of glucose as a source of energy. Required for glucose-induced DRP1-dependent mitochondrial fission and neuron activation in the ventromedial nucleus of the hypothalamus (VMH). This mitochondrial adaptation mechanism modulates the VMH pool of glucose-excited neurons with an impact on systemic glucose homeostasis (By similarity). Regulates ROS levels and metabolic reprogramming of macrophages during the resolution phase of inflammation. Attenuates ROS production in response to IL33 to preserve the integrity of the Krebs cycle required for persistent production of itaconate and subsequent GATA3-dependent differentiation of inflammation-resolving alternatively activated macrophages (By similarity). Can unidirectionally transport anions including L-malate, L-aspartate, phosphate and chloride ions (PubMed:22524567, PubMed:24395786, PubMed:26182433). Does not mediate adaptive thermogenesis (By similarity)","subcellular_location":"Mitochondrion inner membrane","url":"https://www.uniprot.org/uniprotkb/P55851/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/UCP2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/UCP2","total_profiled":1310},"omim":[{"mim_id":"613725","title":"SOLUTE CARRIER FAMILY 25, MEMBER 17; SLC25A27","url":"https://www.omim.org/entry/613725"},{"mim_id":"609911","title":"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 47; SLC25A47","url":"https://www.omim.org/entry/609911"},{"mim_id":"609312","title":"DOPAMINE BETA-HYDROXYLASE, PLASMA; DBH","url":"https://www.omim.org/entry/609312"},{"mim_id":"607946","title":"ADIPONECTIN RECEPTOR 2; ADIPOR2","url":"https://www.omim.org/entry/607946"},{"mim_id":"607945","title":"ADIPONECTIN RECEPTOR 1; ADIPOR1","url":"https://www.omim.org/entry/607945"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":260.0}],"url":"https://www.proteinatlas.org/search/UCP2"},"hgnc":{"alias_symbol":["SLC25A8"],"prev_symbol":["BMIQ4"]},"alphafold":{"accession":"P55851","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P55851","model_url":"https://alphafold.ebi.ac.uk/files/AF-P55851-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P55851-F1-predicted_aligned_error_v6.png","plddt_mean":62.53},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=UCP2","jax_strain_url":"https://www.jax.org/strain/search?query=UCP2"},"sequence":{"accession":"P55851","fasta_url":"https://rest.uniprot.org/uniprotkb/P55851.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P55851/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P55851"}},"corpus_meta":[{"pmid":"10620491","id":"PMC_10620491","title":"The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP.","date":"2000","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10620491","citation_count":640,"is_preprint":false},{"pmid":"22085932","id":"PMC_22085932","title":"UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22085932","citation_count":410,"is_preprint":false},{"pmid":"24395786","id":"PMC_24395786","title":"UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24395786","citation_count":338,"is_preprint":false},{"pmid":"9700198","id":"PMC_9700198","title":"Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians.","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9700198","citation_count":251,"is_preprint":false},{"pmid":"31384530","id":"PMC_31384530","title":"Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKα/UCP2 pathway.","date":"2019","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/31384530","citation_count":227,"is_preprint":false},{"pmid":"25574840","id":"PMC_25574840","title":"UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis.","date":"2015","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/25574840","citation_count":215,"is_preprint":false},{"pmid":"31495690","id":"PMC_31495690","title":"Microglial UCP2 Mediates Inflammation and Obesity Induced by High-Fat Feeding.","date":"2019","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31495690","citation_count":197,"is_preprint":false},{"pmid":"12525856","id":"PMC_12525856","title":"The 'novel' 'uncoupling' proteins UCP2 and UCP3: what do they really do? Pros and cons for suggested functions.","date":"2003","source":"Experimental physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12525856","citation_count":195,"is_preprint":false},{"pmid":"21917523","id":"PMC_21917523","title":"Mitochondrial uncoupling protein 2 (UCP2) in glucose and lipid metabolism.","date":"2011","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21917523","citation_count":181,"is_preprint":false},{"pmid":"18308829","id":"PMC_18308829","title":"Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury.","date":"2008","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/18308829","citation_count":176,"is_preprint":false},{"pmid":"12110661","id":"PMC_12110661","title":"UCP2 and UCP3 in muscle controlling body metabolism.","date":"2002","source":"The Journal of experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12110661","citation_count":152,"is_preprint":false},{"pmid":"16487034","id":"PMC_16487034","title":"The emerging functions of UCP2 in health, disease, and therapeutics.","date":"2006","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/16487034","citation_count":151,"is_preprint":false},{"pmid":"23807210","id":"PMC_23807210","title":"UCP2, a mitochondrial protein regulated at multiple levels.","date":"2013","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/23807210","citation_count":147,"is_preprint":false},{"pmid":"19413946","id":"PMC_19413946","title":"UCP2, not a physiologically relevant uncoupler but a glucose sparing switch impacting ROS production and glucose sensing.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19413946","citation_count":115,"is_preprint":false},{"pmid":"19413708","id":"PMC_19413708","title":"The polymorphisms of UCP2 and UCP3 genes associated with fat metabolism, obesity and diabetes.","date":"2009","source":"Obesity reviews : an official journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/19413708","citation_count":113,"is_preprint":false},{"pmid":"33230296","id":"PMC_33230296","title":"KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth.","date":"2020","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33230296","citation_count":110,"is_preprint":false},{"pmid":"25256770","id":"PMC_25256770","title":"Mitochondrial UCP2 in the central regulation of metabolism.","date":"2014","source":"Best practice & research. Clinical endocrinology & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25256770","citation_count":102,"is_preprint":false},{"pmid":"20227410","id":"PMC_20227410","title":"Uncoupling protein UCP2: when mitochondrial activity meets immunity.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20227410","citation_count":101,"is_preprint":false},{"pmid":"25582199","id":"PMC_25582199","title":"Uncoupling lipid metabolism from inflammation through fatty acid binding protein-dependent expression of UCP2.","date":"2015","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25582199","citation_count":85,"is_preprint":false},{"pmid":"23124112","id":"PMC_23124112","title":"UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23124112","citation_count":83,"is_preprint":false},{"pmid":"15231722","id":"PMC_15231722","title":"Role of uncoupling protein 2 (UCP2) expression and 1alpha, 25-dihydroxyvitamin D3 in modulating adipocyte apoptosis.","date":"2004","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/15231722","citation_count":80,"is_preprint":false},{"pmid":"27795298","id":"PMC_27795298","title":"FABP4/aP2 Regulates Macrophage Redox Signaling and Inflammasome Activation via Control of UCP2.","date":"2017","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27795298","citation_count":79,"is_preprint":false},{"pmid":"29547569","id":"PMC_29547569","title":"Melatonin Balance the Autophagy and Apoptosis by Regulating UCP2 in the LPS-Induced Cardiomyopathy.","date":"2018","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/29547569","citation_count":76,"is_preprint":false},{"pmid":"23607427","id":"PMC_23607427","title":"TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction.","date":"2013","source":"Cardiovascular diabetology","url":"https://pubmed.ncbi.nlm.nih.gov/23607427","citation_count":75,"is_preprint":false},{"pmid":"21779625","id":"PMC_21779625","title":"The role of uncoupling protein 2 (UCP2) on the development of type 2 diabetes mellitus and its chronic complications.","date":"2011","source":"Arquivos brasileiros de endocrinologia e metabologia","url":"https://pubmed.ncbi.nlm.nih.gov/21779625","citation_count":73,"is_preprint":false},{"pmid":"30952098","id":"PMC_30952098","title":"UCP2 ameliorates mitochondrial dysfunction, inflammation, and oxidative stress in lipopolysaccharide-induced acute kidney injury.","date":"2019","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30952098","citation_count":72,"is_preprint":false},{"pmid":"12032169","id":"PMC_12032169","title":"PPARalpha suppresses insulin secretion and induces UCP2 in insulinoma cells.","date":"2002","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/12032169","citation_count":72,"is_preprint":false},{"pmid":"10490803","id":"PMC_10490803","title":"Skeletal muscle UCP2 and UCP3 expression in trained and untrained male subjects.","date":"1999","source":"International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/10490803","citation_count":71,"is_preprint":false},{"pmid":"24853548","id":"PMC_24853548","title":"Mitochondrial retrograde signaling mediated by UCP2 inhibits cancer cell proliferation and tumorigenesis.","date":"2014","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24853548","citation_count":71,"is_preprint":false},{"pmid":"35899624","id":"PMC_35899624","title":"Endothelial UCP2 Is a Mechanosensitive Suppressor of Atherosclerosis.","date":"2022","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/35899624","citation_count":67,"is_preprint":false},{"pmid":"25703824","id":"PMC_25703824","title":"Indoxyl sulfate induces oxidative stress and hypertrophy in cardiomyocytes by inhibiting the AMPK/UCP2 signaling pathway.","date":"2015","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/25703824","citation_count":64,"is_preprint":false},{"pmid":"18701716","id":"PMC_18701716","title":"UCP2 is highly expressed in pancreatic alpha-cells and influences secretion and survival.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18701716","citation_count":61,"is_preprint":false},{"pmid":"23434936","id":"PMC_23434936","title":"UCP2 regulates the glucagon response to fasting and starvation.","date":"2013","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/23434936","citation_count":61,"is_preprint":false},{"pmid":"11322761","id":"PMC_11322761","title":"Insulin and contraction directly stimulate UCP2 and UCP3 mRNA expression in rat skeletal muscle in vitro.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11322761","citation_count":58,"is_preprint":false},{"pmid":"31330574","id":"PMC_31330574","title":"UCP2 gene polymorphisms in obesity and diabetes, and the role of UCP2 in cancer.","date":"2019","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/31330574","citation_count":57,"is_preprint":false},{"pmid":"28258342","id":"PMC_28258342","title":"COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer.","date":"2017","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/28258342","citation_count":57,"is_preprint":false},{"pmid":"28214555","id":"PMC_28214555","title":"Identification of a fatty acid binding protein4-UCP2 axis regulating microglial mediated neuroinflammation.","date":"2017","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/28214555","citation_count":54,"is_preprint":false},{"pmid":"10653476","id":"PMC_10653476","title":"UCP1: the original uncoupling protein--and perhaps the only one? New perspectives on UCP1, UCP2, and UCP3 in the light of the bioenergetics of the UCP1-ablated mice.","date":"1999","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/10653476","citation_count":51,"is_preprint":false},{"pmid":"28104982","id":"PMC_28104982","title":"miRNA-133a-UCP2 pathway regulates inflammatory bowel disease progress by influencing inflammation, oxidative stress and energy metabolism.","date":"2017","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/28104982","citation_count":50,"is_preprint":false},{"pmid":"31932578","id":"PMC_31932578","title":"UCP2-induced hypoxia promotes lipid accumulation and tubulointerstitial fibrosis during ischemic kidney injury.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31932578","citation_count":49,"is_preprint":false},{"pmid":"15196910","id":"PMC_15196910","title":"Links between fatty acids and expression of UCP2 and UCP3 mRNAs.","date":"2004","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/15196910","citation_count":48,"is_preprint":false},{"pmid":"30426490","id":"PMC_30426490","title":"UCP2-dependent improvement of mitochondrial dynamics protects against acute kidney injury.","date":"2018","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30426490","citation_count":48,"is_preprint":false},{"pmid":"31811866","id":"PMC_31811866","title":"UCP2 promotes proliferation and chemoresistance through regulating the NF-κB/β-catenin axis and mitochondrial ROS in gallbladder cancer.","date":"2019","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31811866","citation_count":47,"is_preprint":false},{"pmid":"31081966","id":"PMC_31081966","title":"UCP2 protect the heart from myocardial ischemia/reperfusion injury via induction of mitochondrial autophagy.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31081966","citation_count":47,"is_preprint":false},{"pmid":"34625529","id":"PMC_34625529","title":"An interplay between UCP2 and ROS protects cells from high-salt-induced injury through autophagy stimulation.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34625529","citation_count":46,"is_preprint":false},{"pmid":"34326395","id":"PMC_34326395","title":"Exercise training mitigates ER stress and UCP2 deficiency-associated coronary vascular dysfunction in atherosclerosis.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34326395","citation_count":42,"is_preprint":false},{"pmid":"31461648","id":"PMC_31461648","title":"UCP2 Deficiency Increases Colon Tumorigenesis by Promoting Lipid Synthesis and Depleting NADPH for Antioxidant Defenses.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31461648","citation_count":40,"is_preprint":false},{"pmid":"36499405","id":"PMC_36499405","title":"UCP2 as a Cancer Target through Energy Metabolism and Oxidative Stress Control.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36499405","citation_count":37,"is_preprint":false},{"pmid":"25251374","id":"PMC_25251374","title":"UCP2-related mitochondrial pathway participates in oroxylin A-induced apoptosis in human colon cancer cells.","date":"2015","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25251374","citation_count":37,"is_preprint":false},{"pmid":"30225723","id":"PMC_30225723","title":"Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.","date":"2018","source":"Journal of physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30225723","citation_count":37,"is_preprint":false},{"pmid":"35628447","id":"PMC_35628447","title":"Genipin, an Inhibitor of UCP2 as a Promising New Anticancer Agent: A Review of the Literature.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35628447","citation_count":36,"is_preprint":false},{"pmid":"31071510","id":"PMC_31071510","title":"UCP2 alleviates tubular epithelial cell apoptosis in lipopolysaccharide-induced acute kidney injury by decreasing ROS production.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31071510","citation_count":36,"is_preprint":false},{"pmid":"29221144","id":"PMC_29221144","title":"UCP2 overexpression enhanced glycolysis via activation of PFKFB2 during skin cell transformation.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29221144","citation_count":36,"is_preprint":false},{"pmid":"36699054","id":"PMC_36699054","title":"Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice.","date":"2023","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36699054","citation_count":35,"is_preprint":false},{"pmid":"38927514","id":"PMC_38927514","title":"UCP2, a Member of the Mitochondrial Uncoupling Proteins: An Overview from Physiological to Pathological Roles.","date":"2024","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/38927514","citation_count":34,"is_preprint":false},{"pmid":"37679327","id":"PMC_37679327","title":"Exploring a new mechanism between lactate and VSMC calcification: PARP1/POLG/UCP2 signaling pathway and imbalance of mitochondrial homeostasis.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37679327","citation_count":33,"is_preprint":false},{"pmid":"15485813","id":"PMC_15485813","title":"Heterogeneous nuclear ribonucleoprotein K enhances insulin-induced expression of mitochondrial UCP2 protein.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15485813","citation_count":33,"is_preprint":false},{"pmid":"31182990","id":"PMC_31182990","title":"Upregulation of UCP2 Expression Protects against LPS-Induced Oxidative Stress and Apoptosis in Cardiomyocytes.","date":"2019","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/31182990","citation_count":32,"is_preprint":false},{"pmid":"29079704","id":"PMC_29079704","title":"Mitochondrial Protein UCP2 Controls Pancreas Development.","date":"2017","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/29079704","citation_count":31,"is_preprint":false},{"pmid":"24564667","id":"PMC_24564667","title":"Antioxidant and regulatory role of mitochondrial uncoupling protein UCP2 in pancreatic beta-cells.","date":"2014","source":"Physiological research","url":"https://pubmed.ncbi.nlm.nih.gov/24564667","citation_count":31,"is_preprint":false},{"pmid":"9710252","id":"PMC_9710252","title":"Genomic organization and promoter function of the mouse uncoupling protein 2 (UCP2) gene.","date":"1998","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9710252","citation_count":29,"is_preprint":false},{"pmid":"30235442","id":"PMC_30235442","title":"Genipin Reverses HFD-Induced Liver Damage and Inhibits UCP2-Mediated Pyroptosis in Mice.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30235442","citation_count":29,"is_preprint":false},{"pmid":"12147287","id":"PMC_12147287","title":"Uncoupling protein 2 (UCP2) lowers alcohol sensitivity and pain threshold.","date":"2002","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12147287","citation_count":28,"is_preprint":false},{"pmid":"28276603","id":"PMC_28276603","title":"UCP2 Regulates Embryonic Neurogenesis via ROS-Mediated Yap Alternation in the Developing Neocortex.","date":"2017","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/28276603","citation_count":28,"is_preprint":false},{"pmid":"10333043","id":"PMC_10333043","title":"Effect of thiazolidinediones on expression of UCP2 and adipocyte markers in human PAZ6 adipocytes.","date":"1999","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/10333043","citation_count":27,"is_preprint":false},{"pmid":"12785014","id":"PMC_12785014","title":"Cardiac UCP2 expression and myocardial oxidative metabolism during acute septic shock in the rat.","date":"2003","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/12785014","citation_count":26,"is_preprint":false},{"pmid":"10849580","id":"PMC_10849580","title":"Depot-related and thiazolidinedione-responsive expression of uncoupling protein 2 (UCP2) in human adipocytes.","date":"2000","source":"International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/10849580","citation_count":26,"is_preprint":false},{"pmid":"39900919","id":"PMC_39900919","title":"Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/39900919","citation_count":25,"is_preprint":false},{"pmid":"29887950","id":"PMC_29887950","title":"Overexpressed UCP2 regulates mitochondrial flashes and reverses lipopolysaccharide-induced cardiomyocytes injury.","date":"2018","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/29887950","citation_count":25,"is_preprint":false},{"pmid":"35771638","id":"PMC_35771638","title":"UCP2 modulates cardiomyocyte cell cycle activity, acetyl-CoA, and histone acetylation in response to moderate hypoxia.","date":"2022","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/35771638","citation_count":24,"is_preprint":false},{"pmid":"27376365","id":"PMC_27376365","title":"UCP2 and PLIN1 Expression Affects the Resting Metabolic Rate and Weight Loss on Obese Patients.","date":"2017","source":"Obesity surgery","url":"https://pubmed.ncbi.nlm.nih.gov/27376365","citation_count":23,"is_preprint":false},{"pmid":"33746782","id":"PMC_33746782","title":"Hypoxanthine Induces Muscular ATP Depletion and Fatigue via UCP2.","date":"2021","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33746782","citation_count":23,"is_preprint":false},{"pmid":"10440124","id":"PMC_10440124","title":"Regulation of UCP2 and UCP3 by muscle disuse and physical activity in tetraplegic subjects.","date":"1999","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/10440124","citation_count":23,"is_preprint":false},{"pmid":"11244460","id":"PMC_11244460","title":"UCP2 muscle gene transfer modifies mitochondrial membrane potential.","date":"2001","source":"International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/11244460","citation_count":23,"is_preprint":false},{"pmid":"34183754","id":"PMC_34183754","title":"Activation of UCP2 by anethole trithione suppresses neuroinflammation after intracerebral hemorrhage.","date":"2021","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/34183754","citation_count":22,"is_preprint":false},{"pmid":"31085159","id":"PMC_31085159","title":"UCP2 regulates cholangiocarcinoma cell plasticity via mitochondria-to-AMPK signals.","date":"2019","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31085159","citation_count":21,"is_preprint":false},{"pmid":"26846222","id":"PMC_26846222","title":"Mitochondrial Uncoupling Protein 2 (UCP2) Regulates Retinal Ganglion Cell Number and Survival.","date":"2016","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/26846222","citation_count":21,"is_preprint":false},{"pmid":"33708886","id":"PMC_33708886","title":"The effects of UCP2 on autophagy through the AMPK signaling pathway in septic cardiomyopathy and the underlying mechanism.","date":"2021","source":"Annals of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33708886","citation_count":21,"is_preprint":false},{"pmid":"33763373","id":"PMC_33763373","title":"UCP2 as a Potential Biomarker for Adjunctive Metabolic Therapies in Tumor Management.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33763373","citation_count":20,"is_preprint":false},{"pmid":"38175638","id":"PMC_38175638","title":"UCP2-SIRT3 Signaling Relieved Hyperglycemia-Induced Oxidative Stress and Senescence in Diabetic Retinopathy.","date":"2024","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/38175638","citation_count":19,"is_preprint":false},{"pmid":"25784177","id":"PMC_25784177","title":"UCP2 knockout suppresses mouse skin carcinogenesis.","date":"2015","source":"Cancer prevention research (Philadelphia, Pa.)","url":"https://pubmed.ncbi.nlm.nih.gov/25784177","citation_count":19,"is_preprint":false},{"pmid":"35457171","id":"PMC_35457171","title":"Microglial FABP4-UCP2 Axis Modulates Neuroinflammation and Cognitive Decline in Obese Mice.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35457171","citation_count":18,"is_preprint":false},{"pmid":"37744277","id":"PMC_37744277","title":"CircUCP2 promotes the tumor progression of non-small cell lung cancer through the miR-149/UCP2 pathway.","date":"2023","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/37744277","citation_count":18,"is_preprint":false},{"pmid":"34580604","id":"PMC_34580604","title":"PP2 Ameliorates Renal Fibrosis by Regulating the NF-κB/COX-2 and PPARγ/UCP2 Pathway in Diabetic Mice.","date":"2021","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/34580604","citation_count":18,"is_preprint":false},{"pmid":"36275699","id":"PMC_36275699","title":"UCP2 silencing restrains leukemia cell proliferation through glutamine metabolic remodeling.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36275699","citation_count":17,"is_preprint":false},{"pmid":"15694840","id":"PMC_15694840","title":"Recruitment of mitochondrial uncoupling protein UCP2 after lipopolysaccharide induction.","date":"2005","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15694840","citation_count":17,"is_preprint":false},{"pmid":"26621256","id":"PMC_26621256","title":"Expression of UCP2 in Wistar rats varies according to age and the severity of obesity.","date":"2015","source":"Journal of physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26621256","citation_count":16,"is_preprint":false},{"pmid":"32560241","id":"PMC_32560241","title":"Brain Overexpression of Uncoupling Protein-2 (UCP2) Delays Renal Damage and Stroke Occurrence in Stroke-Prone Spontaneously Hypertensive Rats.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32560241","citation_count":16,"is_preprint":false},{"pmid":"36698892","id":"PMC_36698892","title":"Variability in oxidative stress-related genes (SOD2, CAT, GPX1, GSTP1, NOS3, NFE2L2, and UCP2) and susceptibility to migraine clinical phenotypes and features.","date":"2023","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/36698892","citation_count":16,"is_preprint":false},{"pmid":"25003714","id":"PMC_25003714","title":"Hippocampal UCP2 is essential for cognition and resistance to anxiety but not required for the benefits of exercise.","date":"2014","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25003714","citation_count":16,"is_preprint":false},{"pmid":"39874927","id":"PMC_39874927","title":"The UCP2/PINK1/LC3b-mediated mitophagy is involved in the protection of NRG1 against myocardial ischemia/reperfusion injury.","date":"2025","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/39874927","citation_count":15,"is_preprint":false},{"pmid":"38217303","id":"PMC_38217303","title":"UCP2 promotes NSCLC proliferation and glycolysis via the mTOR/HIF-1α signaling.","date":"2024","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38217303","citation_count":15,"is_preprint":false},{"pmid":"10454128","id":"PMC_10454128","title":"Uncoupling protein-2 (UCP2) and uncoupling protein-3 (UCP3) expression in adipose tissue and skeletal muscle in humans.","date":"1999","source":"International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/10454128","citation_count":15,"is_preprint":false},{"pmid":"30556651","id":"PMC_30556651","title":"UCP2 Overexpression Redirects Glucose into Anabolic Metabolic Pathways.","date":"2019","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/30556651","citation_count":15,"is_preprint":false},{"pmid":"33125133","id":"PMC_33125133","title":"Role and mechanism of FLNa and UCP2 in the development of cervical cancer.","date":"2020","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/33125133","citation_count":14,"is_preprint":false},{"pmid":"23147265","id":"PMC_23147265","title":"An association between -866G/A polymorphism in the promoter of UCP2 and obesity: a meta-analysis.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23147265","citation_count":14,"is_preprint":false},{"pmid":"22177951","id":"PMC_22177951","title":"UCP2 mRNA expression is dependent on glucose metabolism in pancreatic islets.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22177951","citation_count":14,"is_preprint":false},{"pmid":"29928365","id":"PMC_29928365","title":"Expression of UCP2 is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/29928365","citation_count":14,"is_preprint":false},{"pmid":"40707441","id":"PMC_40707441","title":"UCP2 inhibition eliminates pancreatic β cell autoinflammation in T2DM with islet-mitochondrial sequential targeting nanomedicines.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40707441","citation_count":13,"is_preprint":false},{"pmid":"35129048","id":"PMC_35129048","title":"Impact of UCP2 depletion on heat stroke-induced mitochondrial function in human umbilical vein endothelial cells.","date":"2022","source":"International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group","url":"https://pubmed.ncbi.nlm.nih.gov/35129048","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50320,"output_tokens":8009,"usd":0.135547,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17963,"output_tokens":4855,"usd":0.105595,"stage2_stop_reason":"end_turn"},"total_usd":0.241142,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2014,\n      \"finding\": \"UCP2 functions as a metabolite transporter that exchanges malate, oxaloacetate, and aspartate for phosphate plus a proton across the mitochondrial membrane, thereby exporting C4 compounds out of mitochondria. This limits oxidation of acetyl-CoA-producing substrates (e.g., glucose) and enhances glutaminolysis. Reconstitution of UCP2 in lipid vesicles directly demonstrated this transport activity.\",\n      \"method\": \"Reconstitution in lipid vesicles (transport assay), siRNA silencing in HepG2 cells with metabolite profiling, membrane potential and ATP:ADP ratio measurements\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct reconstitution in lipid vesicles with transport assay, combined with cellular loss-of-function and metabolite profiling; multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"24395786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In KRAS-mutant pancreatic ductal adenocarcinoma cells, UCP2 catalyses mitochondrial aspartate efflux required for cytosolic NADPH production via the rewired glutamine metabolic pathway. UCP2 silencing decreased glutaminolysis, lowered NADPH/NADP+ and glutathione/GSSG ratios, raised ROS, and strongly suppressed KRASmut PDAC growth in vitro and in vivo.\",\n      \"method\": \"siRNA/shRNA silencing of UCP2 in PDAC cell lines, metabolic flux analysis, ROS measurements, xenograft mouse models\",\n      \"journal\": \"Nature metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (knockdown, metabolomics, redox assays, in vivo xenograft), replicates and extends the C4 transport mechanism from PMID 24395786\",\n      \"pmids\": [\"33230296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"UCP2 prevents mitochondrial glucose oxidation and facilitates glycolysis via a substrate-shunting mechanism in human pluripotent stem cells. Ectopic UCP2 expression perturbs the metabolic transition during differentiation and impairs hPSC differentiation. UCP2 repression is required for full differentiation potential.\",\n      \"method\": \"Ectopic UCP2 overexpression in hPSCs, siRNA knockdown, metabolic flux measurements (O2 consumption, glycolysis), differentiation assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain- and loss-of-function experiments with specific metabolic and functional phenotypic readouts, multiple orthogonal methods in single study\",\n      \"pmids\": [\"22085932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"UCP2 regulates NLRP3 inflammasome activation through stimulation of fatty acid (lipid) synthesis via fatty acid synthase (FASN) upregulation in macrophages. UCP2-deficient macrophages showed impaired lipid synthesis, downregulated FASN, and suppressed NLRP3-mediated caspase-1 activation and IL-1β/IL-18 production. FASN inhibition phenocopied UCP2 deficiency.\",\n      \"method\": \"UCP2-deficient mice, shRNA knockdown of FASN, chemical inhibitors (C75, cerulenin), LPS challenge, caspase-1 activity assay, cytokine measurement\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO mice plus shRNA/pharmacologic intervention with epistasis between UCP2 and FASN established by multiple methods\",\n      \"pmids\": [\"25574840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Selective microglial deletion of UCP2 prevented HFD-induced changes in mitochondrial dynamics and function, microglia activation, and hypothalamic inflammation, protecting mice from diet-induced obesity with decreased feeding and increased energy expenditure.\",\n      \"method\": \"Microglial-specific Ucp2 conditional knockout mice, HFD feeding, mitochondrial dynamics imaging, synaptic input analysis, POMC neuron activation assays\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO with defined cellular and physiological phenotypes, multiple functional readouts\",\n      \"pmids\": [\"31495690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"UCP2 is expressed at significantly higher levels in pancreatic alpha-cells than beta-cells, where it causes greater mitochondrial uncoupling and lower oxidative phosphorylation efficiency. Reducing UCP2 activity in alpha-cells increased ATP synthesis and altered glucagon secretion in response to low glucose.\",\n      \"method\": \"UCP2-/- mice, mitochondrial membrane potential measurements, ATP/O ratio, glucagon secretion assays in vitro and in vivo\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — UCP2 knockout mice combined with mitochondrial function assays and secretion measurements; multiple orthogonal readouts\",\n      \"pmids\": [\"18701716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Alpha-cell-specific UCP2 deletion impairs blood glucose recovery during hypoglycemia due to attenuated glucagon secretion. UCP2-deleted alpha-cells have higher intracellular ROS from enhanced mitochondrial coupling, which disrupts stimulus-secretion coupling. UCP2 inhibitor genipin on murine and human islets phenocopied the genetic deletion.\",\n      \"method\": \"Alpha-cell-specific UCP2 knockout mice, hypoglycemia challenge, ROS measurement, glucagon secretion assay, genipin pharmacology on murine and human islets\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific KO with mechanistic ROS and secretion readouts; validated with pharmacologic inhibition in human islets\",\n      \"pmids\": [\"23434936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"KLF2 (Krüppel-like factor 2) mediates fluid shear stress-dependent regulation of UCP2 expression in endothelial cells by directly binding the UCP2 promoter. EC-specific Ucp2 deletion promotes atherogenesis; UCP2 suppresses FoxO1-driven proinflammatory transcription via AMPK phosphorylation.\",\n      \"method\": \"Shear stress simulation, KLF2 ChIP on UCP2 promoter, EC-specific Ucp2 KO mice, adeno-associated virus-mediated UCP2 overexpression, RNA-seq, carotid atherosclerosis model\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP binding assay, cell-type-specific KO, AAV overexpression, RNA-seq; multiple orthogonal methods establishing promoter regulation and downstream signaling\",\n      \"pmids\": [\"35899624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The RNA-binding protein hnRNPK binds ucp2 mRNA through sites in the 3'-untranslated region and associates with polysome-coated mitochondria. Exogenous hnRNPK augments insulin-induced mitochondrial UCP2 protein levels without a corresponding increase in ucp2 mRNA, indicating translational regulation.\",\n      \"method\": \"Yeast three-hybrid screen, polysome fractionation, mitochondrial isolation and Western blot, hnRNPK overexpression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast three-hybrid plus polysome fractionation plus protein quantitation; single lab but three orthogonal approaches\",\n      \"pmids\": [\"15485813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In vivo muscle gene transfer of UCP2 cDNA increased UCP2 protein 3.6-fold and caused a significant reduction in mitochondrial membrane potential, demonstrating that UCP2 can uncouple respiration when expressed in skeletal muscle mitochondria.\",\n      \"method\": \"Intramuscular plasmid injection in rats, Western blot for UCP2 protein, spectrofluorometry and flow cytometry for mitochondrial membrane potential\",\n      \"journal\": \"International journal of obesity and related metabolic disorders\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vivo gene transfer with protein-level confirmation and functional mitochondrial readout; single lab, two orthogonal methods\",\n      \"pmids\": [\"11244460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LPS injection in rats recruits UCP2 protein to liver mitochondria (3-fold increase in 3H-GTP binding sites), causes lower mitochondrial membrane potential in hepatocytes, and increases H2O2 production inhibitable by GDP, indicating that recruited UCP2 causes mild uncoupling sufficient to reduce mitochondrial ROS production.\",\n      \"method\": \"In vivo LPS injection, 3H-GTP binding assay, real-time RT-PCR, Western blot, JC1 fluorescence for membrane potential, H2O2 production assay\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (GTP binding, membrane potential, ROS) in single lab establishing protein-level UCP2 recruitment and functional consequence\",\n      \"pmids\": [\"15694840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Transfected human UCP2 localizes exclusively to mitochondria in CHO cells, establishing its subcellular compartment by direct imaging.\",\n      \"method\": \"Transfection of human UCP2 into CHO cells, confocal immunofluorescence microscopy\",\n      \"journal\": \"International journal of obesity and related metabolic disorders\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct localization by immunofluorescence in transfected cells; single method, single lab\",\n      \"pmids\": [\"10849580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PPARα activation in INS-1 insulinoma cells doubles UCP2 expression and reduces glucose-stimulated insulin secretion; this suppression is prevented by CPT-I inhibitor etomoxir, linking PPARα-stimulated fatty acid oxidation through UCP2 to impaired beta-cell insulin secretion.\",\n      \"method\": \"Adenovirus-mediated PPARα overexpression, clofibric acid treatment, CPT-I inhibitor etomoxir, insulin secretion assay, UCP2 mRNA measurement\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — adenoviral overexpression plus pharmacologic epistasis (etomoxir rescue) linking PPARα→UCP2→insulin secretion; single lab, multiple approaches\",\n      \"pmids\": [\"12032169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"UCP2 overexpression in cancer cells restores balance toward oxidative phosphorylation, increases AMPK signaling, downregulates HIF-1α expression, and represses malignant phenotypes. UCP2 acted by controlling substrate routing to mitochondria rather than via membrane potential uncoupling.\",\n      \"method\": \"UCP2 overexpression in cancer cell lines, AMPK signaling analysis, HIF-1α expression, metabolic enzyme expression, tumor phenotype assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function with multiple signaling and metabolic readouts; single lab, mechanistic pathway placement\",\n      \"pmids\": [\"24853548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"UCP2 overexpression activates PFKFB2 via an AKT-dependent signaling pathway in skin cells, elevating fructose-2,6-bisphosphate, PFK-1 activity, glucose uptake and lactate production, promoting glycolysis and cell transformation. PFKFB2 inhibition reversed UCP2-mediated transformation.\",\n      \"method\": \"UCP2 overexpression in JB6 skin cells, PFKFB2 knockdown/inhibition, 13C glucose tracing, AKT inhibition, cell transformation assay\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis between UCP2 and PFKFB2/AKT established by genetic and pharmacologic interventions; single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"29221144\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"UCP2 controls embryonic neurogenesis by inhibiting ROS production; when UCP2 is knocked down or conditionally deleted in developing neocortex, ROS increases, Yap protein accumulates (via decreased ubiquitin-proteasome degradation), progenitor proliferation increases and differentiation decreases. Yap downregulation rescues the UCP2-deficiency phenotype.\",\n      \"method\": \"UCP2 knockdown and conditional KO in mouse embryonic brain, ROS measurement, Yap protein quantitation, Yap genetic rescue experiment\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with genetic rescue establishing UCP2→ROS→Yap pathway; single lab, multiple methods\",\n      \"pmids\": [\"28276603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"UCP2 controls pancreas development by regulating ROS levels: Ucp2-/- fetuses show increased pancreas size, more α- and β-cells, and expanded PDX1+ progenitors associated with increased nuclear NRF2 translocation (indicating increased ROS) and AKT phosphorylation. N-acetylcysteine administration to pregnant Ucp2-/- mice alleviated the phenotype.\",\n      \"method\": \"Ucp2 knockout mice, fetal pancreas analysis, NRF2 nuclear translocation assay, AKT phosphorylation, NAC antioxidant rescue\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO phenotype plus pharmacologic rescue with antioxidant establishing ROS-AKT mechanism; single lab, multiple approaches\",\n      \"pmids\": [\"29079704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"UCP2 deficiency in colon tumors increases oxidized glutathione and protein oxidation, alters glycolytic pathways, and promotes phospholipid synthesis, limiting NADPH availability for antioxidant defense. UCP2 loss enhances colon and intestinal tumorigenesis in AOM/DSS and ApcMin/+ mouse models.\",\n      \"method\": \"Ucp2 KO in AOM/DSS and ApcMin/+ mouse cancer models, NADPH/NADP+ measurement, glutathione oxidation, phospholipid synthesis assays, tumor quantification\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two independent in vivo cancer models plus mechanistic metabolic readouts; single lab\",\n      \"pmids\": [\"31461648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"UCP2 acts as a metabolic oxygen sensor in cardiomyocytes: under moderate hypoxia, UCP2 expression increases, promotes a glycolytic shift, increases acetyl-CoA levels and histone acetylation, and promotes cardiomyocyte cell cycle activity. UCP2-KO mice under hypoxia show reduced cell cycle activity, increased fibrosis and DNA damage.\",\n      \"method\": \"UCP2-KO mouse model, neonatal rat ventricular myocyte culture under hypoxia, acetyl-CoA measurement, histone acetylation assay, cell cycle analysis, mitochondrial membrane potential, mtDNA quantification\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mice plus in vitro mechanistic assays linking UCP2 to acetyl-CoA and histone acetylation; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"35771638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Inhibition or deletion of FABP4/aP2 in macrophages elevates intracellular free fatty acids and upregulates UCP2, reducing ER stress and ROS. Silencing UCP2 in FABP4-deficient macrophages negates the protective effect and increases ER stress, placing UCP2 downstream of FABP4/FFA equilibrium in regulating macrophage oxidative stress.\",\n      \"method\": \"FABP4 KO macrophages, FABP4 pharmacologic inhibition (HTS01037), UCP2 siRNA rescue, mitochondrial protein carbonylation, ROS measurement, ER stress marker expression\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis established by genetic KO and siRNA rescue with multiple oxidative stress readouts; single lab\",\n      \"pmids\": [\"25582199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FABP4 regulates macrophage redox signaling and NLRP3 inflammasome activation via control of UCP2 expression: FABP4-/- macrophages show reduced mitochondrial protein oxidation, attenuated mtUPR, reduced NLRP3/caspase-1 and IL-1β secretion; these effects are partially rescued by UCP2 silencing in FABP4-null macrophages.\",\n      \"method\": \"FABP4-/- macrophages, UCP2 silencing rescue, mitochondrial protein cysteine oxidation, mtUPR markers (HSP60, ClpP, LonP1), caspase-1 cleavage, IL-1β secretion\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis established by KO plus siRNA rescue with multiple mechanistic readouts; replication by same lab of FABP4-UCP2 axis\",\n      \"pmids\": [\"27795298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Upregulation of UCP2 in NASH liver mitochondria induces increased proton leak, which correlates with increased mitochondrial H2O2 production and decreased hepatic ATP content independent of ATPase dysfunction.\",\n      \"method\": \"Mitochondrial isolation from NASH human and rat liver, proton leak kinetics, H2O2 production assay, HNE-protein adduct measurement, UCP2 protein expression (Western blot), ATP measurement\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct mitochondrial functional measurements in human and rat tissue correlating UCP2 protein level with proton leak and ROS; two species, multiple readouts\",\n      \"pmids\": [\"18308829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"UCP2 inhibition (by genipin or siRNA) in pancreatic adenocarcinoma cells increases ROS production, triggers ROS-dependent nuclear translocation of GAPDH, formation of autophagosomes, and LC3-II expression. UCP2 overexpression reduces basal autophagy. Autophagy induced by UCP2 inhibition mediates ROS-dependent cell death.\",\n      \"method\": \"Genipin treatment, UCP2 siRNA knockdown, UCP2 overexpression, GAPDH localization assay, autophagosome formation, LC3-II Western blot, autophagy inhibitors (chloroquine, 3-MA), NAC ROS scavenging\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple complementary interventions (pharmacologic + siRNA + OE) with epistasis via inhibitors; single lab\",\n      \"pmids\": [\"23124112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"UCP2 mediates the interaction between high-salt-induced ROS and autophagy/mitophagy to preserve cell viability in endothelial and renal tubular cells; UCP2 silencing reduces autophagy and mitophagy flux, while UCP2 overexpression increases them. Excessive ROS accumulation upon UCP2 silencing turns off autophagy.\",\n      \"method\": \"UCP2 siRNA silencing, UCP2 overexpression, autophagy flux assay, mitophagy markers, ROS measurement, Tat-Beclin 1 autophagy inducer rescue in UCP2-silenced cells\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with pharmacologic rescue establishing UCP2→ROS→autophagy axis; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"34625529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"UCP2 overexpression in retinal endothelial cells protects against hyperglycemia-induced oxidative stress and senescence by maintaining NAD+ levels and thereby promoting SIRT3 expression and activity; selective SIRT3 inhibition (3-TYP) abolishes the UCP2-mediated protective effect.\",\n      \"method\": \"Adenovirus-mediated UCP2 overexpression and knockdown in HRECs, NAD+ measurement, SIRT3 activity assay, 3-TYP inhibitor epistasis, ROS flow cytometry, SA-β-gal senescence assay\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain/loss-of-function with pharmacologic epistasis establishing UCP2→NAD+→SIRT3 pathway; single lab, multiple methods\",\n      \"pmids\": [\"38175638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In pancreatic β cells under T2DM conditions, IL-1β drives autoinflammation through the UCP2/mtDNA/STING axis: UCP2 inhibition reduces mtDNA release and STING activation, thereby eliminating β-cell autoinflammation.\",\n      \"method\": \"UCP2 inhibitor genipin, nanomedicine (Mito-G) targeting β-cell mitochondria, STING pathway analysis, mtDNA quantitation, IL-1β stimulation model, in vivo T2DM mouse model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — targeted pharmacologic UCP2 inhibition with pathway-specific readouts (mtDNA, STING); single study but in vitro + in vivo, mechanistic pathway established\",\n      \"pmids\": [\"40707441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"UCP2 controls autophagy in cardiomyocytes during sepsis via AMPK: UCP2 silencing reduces AMPK phosphorylation (correlated with changes in upstream kinases pLKB1 and CAMKK2), limits autophagy protein upregulation, and aggravates mitochondrial injury; AMPK agonist AICAR rescues UCP2-KO cardiac phenotype.\",\n      \"method\": \"UCP2 KO mice (CLP sepsis model), UCP2 siRNA in H9C2 cells, AICAR treatment, AMPK phosphorylation, LKB1/CAMKK2 expression, autophagy protein assay (Beclin-1, LC3-I/II, pULK1)\",\n      \"journal\": \"Annals of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO animal plus in vitro silencing with AICAR epistasis establishing UCP2→AMPK→autophagy pathway; single lab\",\n      \"pmids\": [\"33708886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"UCP2 silencing in T-ALL cell lines decreases malate export from mitochondria, disrupting TCA cycle flux and impairing cell proliferation. T-ALL cells relying on glutamine-dependent oxidative metabolism redirect to glycolysis upon UCP2 silencing.\",\n      \"method\": \"UCP2 siRNA in T-ALL cell lines, 13C metabolic tracing, mitochondrial respiration measurement, glycolysis assay, lipid synthesis measurement\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isotopic tracing plus respiratory measurements establishing UCP2 as TCA cycle metabolite exporter in leukemia; single lab, multiple methods\",\n      \"pmids\": [\"36275699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The mouse UCP2 gene spans ~6.3 kb with 8 exons and 7 introns. The promoter lacks TATA and CAAT boxes and is GC-rich; a region from -160 to -678 bp exhibits strong positive regulatory activity. A single transcription start site 369 bp upstream of the translational start was identified.\",\n      \"method\": \"Genomic cloning, primer extension analysis, promoter-reporter transfection assays in 6 cell lines\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter deletion analysis by reporter assay in multiple cell lines combined with primer extension; single lab\",\n      \"pmids\": [\"9710252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"UCP2 overexpression in 3T3-L1 adipocytes reduces mitochondrial membrane potential and ATP production, increases caspase expression, decreases Bcl-2/Bax ratio, and induces apoptosis. Physiological doses of 1,25-(OH)2-D3 restore mitochondrial membrane potential and protect against UCP2-induced apoptosis via suppression of mitochondrial Ca2+.\",\n      \"method\": \"UCP2 overexpression in 3T3-L1 cells, mitochondrial membrane potential measurement, ATP assay, caspase and Bcl-2/Bax expression, Ca2+ measurement, 1,25-(OH)2-D3 dose-response\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, overexpression model with standard apoptosis readouts; limited mechanistic depth on UCP2 mechanism itself\",\n      \"pmids\": [\"15231722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Insulin dose-dependently increases UCP2 mRNA expression in rat skeletal muscle in vitro, independent of glucose uptake. AICAR (AMPK activator) mimics this increase, suggesting AMPK as a mediator of contraction-induced UCP2 upregulation.\",\n      \"method\": \"Isolated rat EDL muscle in vitro incubation, insulin dose-response, electrical contraction, AICAR treatment, RT-PCR for UCP2/UCP3 mRNA\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — mRNA-level readout with pharmacologic AMPK activator; no protein-level or direct AMPK epistasis confirmation; single lab\",\n      \"pmids\": [\"11322761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Chronic hypoxanthine treatment upregulates UCP2 in skeletal muscle, leading to decreased energy substrate storage and enhanced glycolysis causing muscular fatigue. Muscle-specific UCP2 knockout via AAV reversed hypoxanthine-induced effects.\",\n      \"method\": \"Dietary hypoxanthine supplementation in mice, intra-muscle AAV-mediated UCP2 KO, exercise performance test, glycolysis and energy storage assays\",\n      \"journal\": \"Frontiers in physiology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — muscle-specific KO via AAV establishes UCP2 requirement, but mechanism of hypoxanthine→UCP2 induction not fully characterized; single lab\",\n      \"pmids\": [\"33746782\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"UCP2 is a mitochondrial inner membrane transporter (member of SLC25 family) that functions primarily as a C4 metabolite (malate, oxaloacetate, aspartate) exporter rather than a canonical proton-leak uncoupler; by exporting C4 compounds it limits mitochondrial glucose oxidation, promotes glycolysis, and facilitates glutaminolysis—thereby regulating cellular redox homeostasis (NADPH/ROS balance), AMPK and HIF-1α signaling, autophagy/mitophagy, and the secretion of hormones such as insulin and glucagon from pancreatic islets, while also serving as a mechanosensitive gene in endothelial cells under transcriptional control of KLF2.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"UCP2 is a mitochondrial inner-membrane transporter that, rather than acting solely as a proton-leak uncoupler, exports C4 metabolites—malate, oxaloacetate, and aspartate—in exchange for phosphate plus a proton, a transport activity demonstrated directly by reconstitution in lipid vesicles [#0]. By shunting these substrates out of mitochondria, UCP2 limits oxidation of acetyl-CoA-generating fuels such as glucose, promotes glycolysis, and enhances glutaminolysis [#0, #2, #27], thereby positioning the protein as a node controlling cellular redox balance and metabolic fate. This substrate-routing function supports cytosolic NADPH production and glutathione-based antioxidant defense: in KRAS-mutant pancreatic adenocarcinoma, UCP2-mediated aspartate efflux sustains NADPH/GSH and suppresses ROS to drive tumor growth [#1], and UCP2 loss in colon tumors limits NADPH availability and enhances tumorigenesis [#17]. Through its control of ROS, UCP2 governs diverse downstream programs—AMPK activation with HIF-1α suppression and restraint of malignant phenotypes [#13], AKT/PFKFB2-driven glycolysis [#14], ROS-dependent stabilization of Yap during neurogenesis [#15], and pancreatic progenitor expansion via NRF2/AKT signaling [#16]. UCP2 also modulates autophagy and mitophagy in an ROS-dependent manner [#22, #23, #26] and shapes innate immunity by supporting FASN-dependent lipid synthesis for NLRP3 inflammasome activation in macrophages [#3] and by driving the mtDNA/STING autoinflammatory axis in β cells [#25]. Physiologically, UCP2 regulates hormone secretion from pancreatic islets—uncoupling and tuning ROS to control glucagon release from α cells [#5, #6]—and acts as a KLF2-controlled, shear-stress-responsive endothelial gene that suppresses FoxO1-driven inflammation via AMPK to protect against atherogenesis [#7]. UCP2 localizes to mitochondria [#11], and its abundance is set both transcriptionally and translationally, including hnRNPK-mediated control of UCP2 protein levels through its 3'-UTR [#8].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Before its function was understood, the genomic and transcriptional architecture of UCP2 had to be defined to enable regulatory studies.\",\n      \"evidence\": \"Genomic cloning, primer extension, and promoter-reporter assays in multiple cell lines for the mouse gene\",\n      \"pmids\": [\"9710252\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not identify the trans-acting factors binding the positive regulatory region\", \"Promoter analysis in mouse only\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing UCP2's subcellular compartment was prerequisite to any mitochondrial mechanism, confirmed by direct imaging.\",\n      \"evidence\": \"Transfection of human UCP2 into CHO cells with confocal immunofluorescence\",\n      \"pmids\": [\"10849580\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single localization method in an overexpression system\", \"Does not address submitochondrial topology\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"An early functional question—whether UCP2 can actually uncouple respiration—was answered in vivo in skeletal muscle.\",\n      \"evidence\": \"Intramuscular plasmid gene transfer in rats with membrane potential readouts\",\n      \"pmids\": [\"11244460\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Overexpression may force non-physiological uncoupling\", \"Does not distinguish proton leak from metabolite transport\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Cell-type-resolved analysis showed UCP2 tunes islet hormone secretion, linking mitochondrial coupling to glucagon physiology.\",\n      \"evidence\": \"UCP2-/- mice with mitochondrial membrane potential, ATP/O, and glucagon secretion assays comparing alpha- and beta-cells\",\n      \"pmids\": [\"18701716\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism connecting coupling efficiency to secretory machinery not detailed\", \"Whole-body KO does not isolate alpha-cell-autonomous effects\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"UCP2 abundance was shown to be set post-transcriptionally, revealing translational control as a regulatory layer.\",\n      \"evidence\": \"Yeast three-hybrid screen, polysome fractionation, and hnRNPK overexpression tracking UCP2 protein vs mRNA\",\n      \"pmids\": [\"15485813\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; mechanism of insulin-induced translational activation not fully resolved\", \"Physiological importance in vivo untested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"The defining mechanistic advance recast UCP2 as a C4-metabolite exporter rather than a simple uncoupler, explaining how it reroutes glucose vs glutamine metabolism.\",\n      \"evidence\": \"Reconstitution in lipid vesicles with transport assay plus siRNA silencing and metabolite profiling in HepG2 cells\",\n      \"pmids\": [\"24395786\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative in vivo contribution of transport vs residual proton leak not quantified\", \"Structural basis of substrate selectivity unresolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Alpha-cell-specific deletion tied UCP2-controlled ROS to stimulus-secretion coupling and counter-regulatory glucagon release during hypoglycemia.\",\n      \"evidence\": \"Alpha-cell-specific KO mice with hypoglycemia challenge, ROS and secretion assays, validated by genipin in human islets\",\n      \"pmids\": [\"23434936\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genipin is not UCP2-selective\", \"Link between ROS and exocytotic machinery not molecularly defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"UCP2 was placed in innate immune control by coupling its activity to FASN-dependent lipid synthesis needed for NLRP3 inflammasome activation.\",\n      \"evidence\": \"UCP2-deficient mice, FASN knockdown and inhibitors, caspase-1 and cytokine assays establishing UCP2-FASN epistasis\",\n      \"pmids\": [\"25574840\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How metabolite transport drives FASN upregulation mechanistically not shown\", \"Relationship to UCP2's antioxidant role in same cells unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Independent cancer studies linked UCP2 substrate routing to AMPK/HIF-1α signaling and the glycolytic phenotype.\",\n      \"evidence\": \"UCP2 overexpression in cancer lines with AMPK, HIF-1α, and tumor phenotype readouts\",\n      \"pmids\": [\"24853548\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal order between metabolic shift and AMPK/HIF-1α not fully dissected\", \"Single overexpression context\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Multiple developmental and signaling studies converged on UCP2-controlled ROS as the effector regulating Yap, NRF2/AKT, and progenitor fate.\",\n      \"evidence\": \"Conditional KO/knockdown in neocortex and pancreas with ROS, Yap, NRF2 readouts and genetic/antioxidant rescue; AKT/PFKFB2 epistasis in skin cells with 13C tracing\",\n      \"pmids\": [\"28276603\", \"29079704\", \"29221144\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether ROS effects stem from metabolite transport or residual uncoupling not resolved per study\", \"Tissue specificity of downstream effectors not generalized\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"UCP2-dependent aspartate efflux was shown to fuel cytosolic NADPH/glutathione and ROS control required for KRAS-mutant PDAC growth, extending the C4 transport model to cancer redox biology.\",\n      \"evidence\": \"siRNA/shRNA silencing in PDAC lines, metabolic flux, redox assays, and xenografts\",\n      \"pmids\": [\"33230296\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generalizability beyond KRAS-mutant context not addressed\", \"Does not test whether transport-dead UCP2 abolishes the effect\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"In vivo cancer models showed UCP2 loss impairs NADPH-dependent antioxidant defense and promotes intestinal tumorigenesis, and microglial UCP2 was tied to diet-induced obesity and hypothalamic inflammation.\",\n      \"evidence\": \"Ucp2 KO in AOM/DSS and ApcMin/+ models with NADPH/GSH readouts; microglia-specific conditional KO with HFD and mitochondrial dynamics imaging\",\n      \"pmids\": [\"31461648\", \"31495690\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Tissue-of-origin cell-autonomy in tumor models not fully isolated\", \"Connection between microglial mitochondrial dynamics and feeding circuits incompletely mapped\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"UCP2 was identified as a KLF2-controlled, shear-stress-responsive endothelial gene that restrains FoxO1 inflammation via AMPK and protects against atherosclerosis, and as a metabolic oxygen sensor regulating cardiomyocyte cell cycle through acetyl-CoA/histone acetylation.\",\n      \"evidence\": \"KLF2 ChIP on UCP2 promoter, EC-specific KO, AAV overexpression, RNA-seq, atherosclerosis model; UCP2-KO cardiomyocytes under hypoxia with acetyl-CoA and histone acetylation assays\",\n      \"pmids\": [\"35899624\", \"35771638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical link between transport activity and AMPK phosphorylation not established\", \"How UCP2 senses oxygen mechanistically remains open\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Isotopic tracing confirmed UCP2 exports malate to sustain TCA flux in glutamine-dependent leukemia, reinforcing the transporter model across cancer types.\",\n      \"evidence\": \"UCP2 siRNA in T-ALL lines with 13C tracing, respiration, and glycolysis assays\",\n      \"pmids\": [\"36275699\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lineage tested\", \"Does not measure direct transport vs indirect metabolic adaptation\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Recent work extended UCP2 into autophagy/mitophagy control and a β-cell mtDNA/STING autoinflammatory axis, integrating its redox role with cell survival and inflammation.\",\n      \"evidence\": \"Gain/loss-of-function with ROS, autophagy flux, SIRT3, mtDNA and STING readouts across endothelial, renal, cardiac, and β-cell systems, including genipin and nanomedicine targeting in T2DM models\",\n      \"pmids\": [\"23124112\", \"34625529\", \"33708886\", \"38175638\", \"40707441\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Genipin specificity limits causal attribution to UCP2\", \"Whether mtDNA release is a direct consequence of transport activity unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how UCP2's biochemically defined C4-metabolite transport activity mechanistically generates its many downstream signaling outputs (AMPK, HIF-1α, Yap, STING) and whether residual proton-leak uncoupling contributes independently.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No transport-dead mutant used to separate transport from uncoupling in signaling phenotypes\", \"No high-resolution structure defining substrate selectivity\", \"Quantitative in vivo flux contribution of UCP2 transport not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 27]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [0, 27]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 8, 11, 21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 2, 27]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [1, 10, 17, 24]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 20, 25]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [22, 23, 26]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 13, 14]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"hnRNPK\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}